Dose of intravenous immunoglobulins in chronic inflammatory demyelinating polyneuropathy

Journal of the Peripheral Nervous System

Volumn 11, Issue 4, 2006, Pages 325-329

  Rajabally, Yusuf A ^a   Seow, Hanny ^a   Wilson, Patrick ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

Chronic inflammatory demyelinating polyneuropathy; Disease duration; Dose; Frequency; Intravenous immunoglobulins; Minimal; Severity; Weight

Indexed keywords

IMMUNOGLOBULIN;

ADULT; AGED; AMPLITUDE MODULATION; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; LOW DRUG DOSE; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; TITRIMETRY;

AGE OF ONSET; AGED; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; RETROSPECTIVE STUDIES;

EID: 33750896818     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/j.1529-8027.2006.00105.x     Document Type: Review

References (13)

1. Donofrio PD, Busis N (2002). Regulatory and reimbursement issues in treating patients with immune-mediated neuropathies. Neurology 59:S41-S45.
2. Dyck PJ, Litchy WJ, Kratz KM, Suarez GA, Low PA, Pineda AA, Windebank AJ, Karnes JL, O'Brien PC (1994). A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 36:838-845.
3. Gajdos P, Tranchant C, Clair B, Bolgert F, Eymard B, Stojkovic T, Attarian S, Chevret S; Myasthenia Gravis Clinical Study Group (2005). Treatment of myasthenia gravis exacerbations with intravenous immunoglobulin: a randomized double-blind clinical trial. Arch Neurol 62:1689-1693.
4. Hadden RD, Hughes RA (2003). Management of inflammatory neuropathies. J Neurol Neurosurg Psychiatry 74:ii9-ii14.
5. Hahn AF, Bolton CF, Zochodone D, Feasby TE (1996). Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study. Brain 119:1067-1077.
6. Hughes RAC, Bouche P, Cornblath DR, Evers E, Hadden RD, Hahn AF, Illa I, Koski CL, Léger JM, Nobile-Orazio E, Pollard JD, Sommer C, Van den Bergh P, van Doorn P, van Schaik IN (2005). European Federation of Neurological Sciences/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 10:220-228.
7. Koski CL (2002). Therapy of CIDP and related immune-mediated neuropathies. Neurology 59:S22-S27.
8. Magda P, Latov N, Brannagan TH III, Weimer LH, Chin RL, Sander HW (2003). Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy. Arch Neurol 60:1755-1759.
9. McCrone P, Chisholm D, Knapp M, Hughes R, Comi G, Dalakas MC, Illa I, Kilindireas C, Nobile-Orazio E, Swan A, Van den Bergh P, Willison HJ; The INCAT Study Group (2003). Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 10:687-694.
10. Mendell JR, Barohn RJ, Freimer ML, Kissel JT, King W, Nagaraja HN, Rice R, Campbell WW, Donofrio PD, Jackson CE, Lewis RA, Shy M, Simpson DM, Parry GJ, Rivner MH, Thornton CA, Bromberg MB, Tandan R, Harati Y, Giuliani MJ; The Working Group on Peripheral Neuropathy (2001). Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 56:445-449.
11. Nobile-Orazio E, Terenghi F (2005). IVIg in idiopathic autoimmune neuropathies: analysis in the light of latest results. J Neurol 252:I7-I13.
12. Van den Bergh PYK, Piéret F (2004). Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 29:565-574.
13. van Doorn PA (2004). Intravenous Immunoglobulin for Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Adult Patients. In: Intravenous Immunoglobulins in the Third Millenium. Dalakas MC, Späth PJ (Eds). The Parthenon Publishing Group, London, pp 171-180.